CD274 and neoplasm: Depletion of myeloid cells was found to prevent the initiation of KRAS-driven pancreatic tumorigenesis by downregulating the secretion of programmed cell death ligand 1 (PD-L1), which restored the anti-tumor activities of CD8+ T cells [161].